9:56AM ET 5/23/2022 MT NewswiresJounce Therapeutics (JNCE) has an average rating of outperform and price targets ranging from $7 to $20, according to analysts polled by Capital IQ. (MT...
2:10PM ET 5/11/2022 MT NewswiresShares of Jounce Therapeutics (JNCE) were down almost 19% in Wednesday afternoon trading after Baird downgraded the clinical-stage drugmaker's stock to...
7:23AM ET 5/11/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
8:02AM ET 5/06/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...